Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

As AI continues to evolve, radiologists must once again embrace change

Healthcare technology is constantly changing, something radiologists know all too well. And while some within the specialty have expressed fear or concern over the continued rise of AI, a new commentary in Clinical Radiology noted that it’s all par for the course—and radiologists must rise to the occasion yet again.

Thumbnail

25 participants advance in $1M AI challenge

CMS announced Thursday, Oct. 31, that 25 participants have advanced in the agency’s Artificial Intelligence Health Outcomes Challenge, putting them one step closer to earning $1 million in prize money.

Thumbnail

Majority of physicians optimistic about AI’s impact on healthcare

Fifty-three percent of physicians say they are optimistic about AI’s potential effect on healthcare, according to a new survey of more than 1,700 physicians published by the Doctors Company.

Thumbnail

AI provides personalized care for MSK disease

Deep learning can provide accurate measurements of a patient’s musculoskeletal (MSK) system by evaluating CT scans, according to findings published in IEEE Transactions on Medical Imaging.

Thumbnail

AI IDs cancer patients at risk of short-term mortality

Machine learning algorithms can be used to identify cancer patients at risk of short-term mortality, according to a new study published in JAMA Network Open. This helps providers plan for necessary conversations about end-of-life preferences.

Thumbnail

Facebook, NYU continue collaboration to speed up medical imaging with AI

Facebook and the NYU School of Medicine made headlines back in August 2018 when they announced their plan to improve MRI times using AI.

Thumbnail

AI helps predict when DCIS will progress to invasive breast cancer

Researchers have uncovered a new way to determine when ductal carcinoma in situ (DCIS) is most likely to progress to a more invasive cancer, according to new findings published in Breast Cancer Research.

Thumbnail

These companies want to see your poop—all in the name of AI

People often stare at their phones while using the restroom, scrolling through emails and social media posts to help pass the time. Now, however, two companies are asking phone-toting individuals to do something else before they flush: snap a quick photo of their poop.